HomeXRTX • NASDAQ
add
XORTX Therapeutics Inc
Previous close
$0.84
Day range
$0.82 - $0.87
Year range
$0.80 - $2.98
Market cap
4.20M CAD
Avg Volume
31.35K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 791.05K | 27.69% |
Net income | -698.67K | 76.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -782.70K | -33.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.90M | -50.59% |
Total assets | 3.50M | -42.18% |
Total liabilities | 757.35K | -78.72% |
Total equity | 2.74M | — |
Shares outstanding | 3.79M | — |
Price to book | 1.17 | — |
Return on assets | -52.09% | — |
Return on capital | -64.50% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -698.67K | 76.86% |
Cash from operations | -643.73K | 50.63% |
Cash from investing | -3.38K | -29.05% |
Cash from financing | 67.58K | -96.03% |
Net change in cash | -578.41K | -249.16% |
Free cash flow | -445.51K | 55.36% |
About
Founded
2011
Headquarters
Website
Employees
3
